Moderna
MRNA
#270
Rank
S$115.01 B
Marketcap
S$288.09
Share price
14.21%
Change (1 day)
707.14%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -S$3.92 Billion

According to Moderna 's latest financial reports the company's current earnings are S$2.21 Billion. In 2025 the company made an earning of -S$3.54 Billion, an increase over its 2024 earnings that were of -S$4.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$3.92 Billion10.98%
2025 -S$3.54 Billion-23.03%
2024 -S$4.59 Billion-8.22%
2023 -S$5 Billion-140.65%
2022 S$12.29 B-27.81%
2021 S$17.03 B-1911.15%
2020 -S$0.95 Billion44.7%
2019 -S$0.65 Billion28.63%
2018 -S$0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.55 B-960.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$19.87 B-609.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$9.84 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-S$60.73 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.48 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.43 B-136.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-S$0.21 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA